Meeting of the National Vaccine Advisory Committee; Correction, 57497 [2022-20276]

Download as PDF Federal Register / Vol. 87, No. 181 / Tuesday, September 20, 2022 / Notices DEPARTMENT OF HEALTH AND HUMAN SERVICES Meeting of the National Vaccine Advisory Committee; Correction Office of Infectious Disease and HIV/AIDS Policy, Office of the Assistant Secretary for Health, Office of the Secretary, Department of Health and Human Services. ACTION: Notice; correction. AGENCY: The Office of the Assistant Secretary for Health published a document in the Federal Register of September 14, 2022, announcing a public meeting to be held meeting June 22–23, 2022. The document referred to the incorrect month and should have read September 22–23, 2022 instead. We also noticed a minor typo to correct and is described in the SUPPLEMENTARY INFORMATION section. FOR FURTHER INFORMATION CONTACT: Ann Aikin, Acting Designated Federal Officer, at the Office of Infectious Disease and HIV/AIDS Policy, U.S. Department of Health and Human Services, Mary E. Switzer Building, Room L618, 330 C Street SW, Washington, DC 20024. Email: nvac@ hhs.gov. Phone: 202–494–1719. SUPPLEMENTARY INFORMATION: SUMMARY: Correction In the Federal Register of September 14, 2022, in FR Doc. 2022–19849, on page 56427 in the third column, correct the first sentence of the DATES caption to read: ‘‘The meeting will be held September 22–23, 2022.’’ On page 56428 in the first column, under SUPPLEMENTARY INFORMATION, in the second paragraph, first sentence, correct the word ‘‘influenza’’ by adding a ‘‘z’’. Dated: September 14, 2022. Ann Aikin, Acting Designated Federal Official, Office of the Assistant Secretary for Health. [FR Doc. 2022–20276 Filed 9–19–22; 8:45 am] BILLING CODE 4150–44–P DEPARTMENT OF HEALTH AND HUMAN SERVICES lotter on DSK11XQN23PROD with NOTICES1 National Institutes of Health National Center for Complementary & Integrative Health; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the VerDate Sep<11>2014 17:48 Sep 19, 2022 Jkt 256001 provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Center for Complementary and Integrative Health Special Emphasis Panel; Exploratory Clinical Trials of Mind and Body Interventions (MB). Date: October 13–14, 2022. Time: 12 p.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: National Center for Complementary and Integrative Democracy II, 6707 Democracy Blvd., Bethesda, MD 20892 (Virtual Meeting). Contact Person: SUSHMITA Purkayastha, Ph.D., Scientific Review Officer, Office of Scientific Review, Division of Extramural Activities, NCCIH/NIH, 6707 Democracy Boulevard, Suite 401, Bethesda, MD 20892– 5475, sushmita.purkayastha@nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.213, Research and Training in Complementary and Alternative Medicine, National Institutes of Health, HHS.) Dated: September 15, 2022. Victoria E. Townsend, Program Analyst, Office of Federal Advisory Committee Policy. 57497 Date: November 2–3, 2022. Time: 10 a.m. to 2 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, National Institute of General Medical Sciences, Natcher Building, 45 Center Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Nina Sidorova, Ph.D., Scientific Review Officer, Office of Scientific Review, National Institute of General Medical Sciences, National Institutes of Health, 45 Center Drive, Room 3An.22, Bethesda, MD 20892–6200, 301–594–3663, sidorova@ nigms.nih.gov. Information is also available on the Institute’s/Center’s home page: www.nigms.nih.gov/, where an agenda and any additional information for the meeting will be posted when available. (Catalogue of Federal Domestic Assistance Program Nos. 93.375, Minority Biomedical Research Support; 93.821, Cell Biology and Biophysics Research; 93.859, Pharmacology, Physiology, and Biological Chemistry Research; 93.862, Genetics and Developmental Biology Research; 93.88, Minority Access to Research Careers; 93.96, Special Minority Initiatives; 93.859, Biomedical Research and Research Training, National Institutes of Health, HHS.) Dated: September 14, 2022. Miguelina Perez, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2022–20236 Filed 9–19–22; 8:45 am] BILLING CODE 4140–01–P [FR Doc. 2022–20283 Filed 9–19–22; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institutes of Health National Institute of General Medical Sciences; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of General Medical Sciences Special Emphasis Panel; Review of Centers of Biomedical Research Excellence (COBRE) Phase 3 (P30) Applications. PO 00000 Frm 00046 Fmt 4703 Sfmt 4703 National Institute of General Medical Sciences; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of General Medical Sciences Special Emphasis Panel; Review of Support for Research Excellence (SuRE) Program (R16). Date: October 27, 2022. Time: 10:00 a.m. to 3:00 p.m. Agenda: To review and evaluate grant applications. E:\FR\FM\20SEN1.SGM 20SEN1

Agencies

[Federal Register Volume 87, Number 181 (Tuesday, September 20, 2022)]
[Notices]
[Page 57497]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-20276]



[[Page 57497]]

=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


Meeting of the National Vaccine Advisory Committee; Correction

AGENCY: Office of Infectious Disease and HIV/AIDS Policy, Office of the 
Assistant Secretary for Health, Office of the Secretary, Department of 
Health and Human Services.

ACTION: Notice; correction.

-----------------------------------------------------------------------

SUMMARY: The Office of the Assistant Secretary for Health published a 
document in the Federal Register of September 14, 2022, announcing a 
public meeting to be held meeting June 22-23, 2022. The document 
referred to the incorrect month and should have read September 22-23, 
2022 instead. We also noticed a minor typo to correct and is described 
in the SUPPLEMENTARY INFORMATION section.

FOR FURTHER INFORMATION CONTACT: Ann Aikin, Acting Designated Federal 
Officer, at the Office of Infectious Disease and HIV/AIDS Policy, U.S. 
Department of Health and Human Services, Mary E. Switzer Building, Room 
L618, 330 C Street SW, Washington, DC 20024. Email: [email protected]. 
Phone: 202-494-1719.

SUPPLEMENTARY INFORMATION: 

Correction

    In the Federal Register of September 14, 2022, in FR Doc. 2022-
19849, on page 56427 in the third column, correct the first sentence of 
the DATES caption to read: ``The meeting will be held September 22-23, 
2022.''
    On page 56428 in the first column, under SUPPLEMENTARY INFORMATION, 
in the second paragraph, first sentence, correct the word ``influenza'' 
by adding a ``z''.

    Dated: September 14, 2022.
Ann Aikin,
Acting Designated Federal Official, Office of the Assistant Secretary 
for Health.
[FR Doc. 2022-20276 Filed 9-19-22; 8:45 am]
BILLING CODE 4150-44-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.